Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in GSK Lawsuit - GSK
Portfolio Pulse from
Law firm Levi & Korsinsky is pursuing a class action securities lawsuit against GSK plc, alleging the company misled investors about Zantac's safety and NDMA risks between February 2020 and August 2022. The lawsuit claims GSK knew about NDMA sources for decades before withdrawing the drug from the market, potentially misleading shareholders about potential liabilities.
March 21, 2025 | 11:45 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Class action lawsuit alleges GSK misled investors about Zantac's safety and potential cancer risks, which could result in financial and reputational damages.
The lawsuit alleges significant misrepresentations about Zantac's safety, which could lead to financial penalties, reputational damage, and potential investor loss of confidence.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100